D
Regeneron Pharmaceuticals, Inc. REGN
$689.50 -$28.66-3.99%
Recommendation
Sell
Prev Close
$718.16
Volume
808,455
Avg Vol (90D)
905,817
Market Cap
$76.86B
Dividend & Yield
$0.88(0.12%)
52-Week Range
$642.00 - $1,211.20
P/E (TTM)
18.76
EPS (TTM)
$38.29
My Lists My Alerts
Rating
Reward
C
Fair
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Excellent
Solvency Index
Excellent
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Regeneron: Is It the Perfect Biotech Stock for Value and Growth?
2/27/2025 - MarketBeat
What Did Jim Cramer Say About These 19 Stocks Recently?
3/12/2025 - Insider Monkey
Is Regeneron Pharmaceuticals, Inc. (REGN) the Best Pharma Stock to Buy According to Hedge Funds?
3/12/2025 - Insider Monkey
Video: Nasdaq 100 Movers: REGN, APP
3/12/2025 - Market News Video
40 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Bought by OFI Invest Asset Management
3/12/2025 - Ticker Report
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Position Boosted by Wealthfront Advisers LLC
3/12/2025 - MarketBeat
PNC Financial Services Group Inc. Decreases Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
3/12/2025 - MarketBeat
Regeneron Science Talent Search 2025 Awards More Than $1.8 Million to High School Seniors for Innovative Research on Classifying Celestial Objects, Treating a Rare Muscle Disease and Solving a Long-Standing Math Problem
3/12/2025 - PR Newswire
Regeneron Science Talent Search 2025 Awards More Than $1.8 Million to High School Seniors for Innovative Scientific Research on Classifying Objects in Space, Treating a Rare Muscle Disease and Solving a Long-Standing Math Problem
3/12/2025 - Globe Newswire
11 Best Pharma Stocks to Buy According to Hedge Funds
3/11/2025 - Insider Monkey
Regeneron Pharmaceuticals (NASDAQ:REGN) Shares Up 4.7% - What's Next?
3/11/2025 - MarketBeat
Regeneron Pharmaceuticals, Inc. (REGN) Leerink Partners 2025 Global Healthcare Conference Call Transcript
3/11/2025 - SeekingAlpha
Regeneron Pharmaceuticals, Inc. (REGN) Leerink Partners 2025 Global Healthcare Conference Call Transcript
3/11/2025 - Seeking Alpha: Transcripts
Regeneron Pharmaceuticals Inc. Takes $845,000 Position in Adverum Biotechnologies, Inc. (NASDAQ:ADVM)
3/11/2025 - MarketBeat
Regeneron Pharmaceuticals Inc. Makes New $931,000 Investment in Adicet Bio, Inc. (NASDAQ:ACET)
3/11/2025 - MarketBeat
1,254,827 Shares in 2seventy bio, Inc. (NASDAQ:TSVT) Acquired by Regeneron Pharmaceuticals Inc.
3/11/2025 - MarketBeat
Regeneron Pharmaceuticals Inc. Buys Shares of 3,702,995 Intellia Therapeutics, Inc. (NASDAQ:NTLA)
3/11/2025 - MarketBeat
Regeneron Pharmaceuticals Inc. Buys New Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
3/11/2025 - MarketBeat
Daiwa Securities Group Inc. Acquires 1,278 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
3/11/2025 - MarketBeat
Regeneron Pharmaceuticals, Inc. (REGN): Hedge Funds Are Bullish On This Oversold Blue Chip Stock Now
3/10/2025 - Insider Monkey
Regeneron Pharmaceuticals, Inc. Investors: Please contact the Portnoy Law Firm to recover your ...
3/10/2025 - GuruFocus
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. ...
3/10/2025 - GuruFocus
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
3/10/2025 - Business Wire
Levi & Korsinsky Notifies Shareholders of Regeneron Pharmaceuticals, Inc. ...
3/10/2025 - GuruFocus
Biogen Stock Is Mutating Into a Value Play
2/20/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$14.20B
EBITDA (TTM)
$4.60B
EBIT (TTM)
$4.12B
Net Income (TTM)
$4.41B
Balance Sheet
Total Assets (Q)
$37.76B
Total Debt (Q)
$2.94B
Total Liabilities (Q)
$8.41B
Book Value Per Share (Q)
$273.57
Cash Flow
Cash from Operations (TTM)
$4.42B
Cash from Investing (TTM)
-$2.47B
Cash from Financing (TTM)
-$2.20B
Net Change in Cash (TTM)
-$248.80M
Filings
Filing Date
Wednesday, February 5, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Beginning of May (est)
Price History
Loading...
Beta
0.46
7-Day Total Return
0.68%
30-Day Total Return
0.59%
60-Day Total Return
-10.69%
90-Day Total Return
-25.55%
Year to Date Total Return
-3.47%
1-Year Total Return
-28.87%
2-Year Total Return
-8.23%
3-Year Total Return
5.18%
5-Year Total Return
59.85%
52-week Low
Feb 04, 2025 - $642.00
52-week High
Aug 27, 2024 - $1,211.20
Valuation
Market Cap
$76.86B - Large Cap
Enterprise Value
$61.89B
Price/Sales (TTM)
5.75
Price/Book (Q)
2.63
Dividends and Shares
Shares Outstanding
113.80M
Dividend Per Share (Most Recent)
$0.88
Dividend Per Share (TTM)
$0.88
Corporate Info
Website
www.regeneron.com
Phone Number
914 847 7000
Address
777 Old Saw Mill River Road
Tarrytown, NY 10591-6707
Country
United States
Year Founded
1988
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company’s products include EYLEA injection to... more
NASDAQ 03/12/2025 4:00PM Eastern Quotes delayed
Weiss Ratings